Study on the social and economic burden of antiseptic resistance of two popular drug-resistant bacteria
10.3760/cma.j.issn.1000-6672.2018.08.012
- VernacularTitle: 两种常见耐药菌抗菌药物耐药情况的社会经济负担研究
- Author:
Jiangyun CHEN
1
;
Kan TIAN
;
Chang YIN
;
Rui MIN
1
;
Xue BAI
1
;
Pengqian FANG
1
Author Information
1. Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
- Publication Type:Journal Article
- Keywords:
Klebsiella pneumoniae;
Escherichia coli;
Drug resistance, bacterial;
Social and economic burdens
- From:
Chinese Journal of Hospital Administration
2018;34(8):663-666
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To study the socioeconomic burden of bacterial resistance incurred by taking carbapenem-resistant Klebsiella pneumoniae and cefotaxime-resistant Escherichia coli as examples.
Methods:Such indexes as disability-adjusted life years and health utility values were used to conduct a socioeconomic analysis of drug resistance.
Results:The economic burden caused by Klebsiella pneumoniae and Escherichia coli resistance among inpatients of 187 members of the national antiseptic drug clinical application monitoring network in 2015 was as high as 260.498 9 million yuan and 352.325 8 million yuan respectively. The years of healthy life lost due to disability were 4 658.02 years and 6 346.97 years respectively.
Conclusions:This study introduced indexes such as disability-adjusted life years and health utility values, to scientifically innovate the measurement of the economic burden of drug resistance from the perspective of economic burden of diseases.
